Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cilostazol (Pletaal SR Capsule) for peripheral arterial disease due to chronic occlusive arterial disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Pletaal SR Capsule (cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Chronic Occlusive Arterial Disease | Phase 4 | Status: COMPLETED